The determination of matrix metalloproteinase 9 activity and gene expression levels in Behcet’s disease patients with aneurysmal complications
- 15 September 2010
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 30 (4) , 515-519
Abstract
The information concerning aneurysmal progress in Behcet’s disease is still insufficient, while researches in the role of matrix metalloproteinases (MMPs) in aneurysmal formation are rapidly expanding. The goal of the present study is to investigate the role of metalloproteinase 9 (MMP-9) in vascular complications which is observed in 10% of Behcet’s disease patients. Three groups have been studied; patients with Behcet’s disease, patients with Behcet’s disease who have vascular problems (vasculo-Behcet’s), and patients with abdominal aortic aneurysm (AAA). The third group was used as a control. The activity and gene expression levels of MMP-9 in plasma have been determined. We showed that compared to AAA patients there was no difference in the MMP-9 activity in Behcet’s disease patients (vascular and non-vascular). We also evaluated the gene expression level and activity of MMP-9 for every patient. The increase in the gene expression level for MMP-9 could only be detected at two patients. One of them was Behcet’s, the other was AAA patient. It is surprising that MMP levels of these patients were different. While the patient with Behcet’s had low protein level, another patient with AAA had high of MMP-9 level. This result suggested to us that the relationship between gene expression and active protein level is not correlated. It is not sufficient alone to determine MMPs levels for evaluating the pathogenesis. At the same time gene expression and the level of active protein should be assessed together.Keywords
This publication has 37 references indexed in Scilit:
- Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet diseaseAnnals of the Rheumatic Diseases, 2009
- Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a meta-analysisInteractive CardioVascular and Thoracic Surgery, 2009
- Homocysteine May Involve in the Pathogenesis of Behcet′s Disease by Inducing InflammationMediators of Inflammation, 2008
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007
- Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic AneurysmAnnals of Vascular Surgery, 2007
- Matrix metalloproteinases in peripheral vascular diseaseJournal of Vascular Surgery, 2007
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Difference in Matrix-Degrading Protease Expression and Activity Between Thrombus-Free and Thrombus-Covered Wall of Abdominal Aortic AneurysmArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Activated forms of MMP2 and MMP9 in abdominal aortic aneurysmsJournal of Vascular Surgery, 1996
- Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.Journal of Clinical Investigation, 1995